9832353|t|Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
9832353|a|We report the case of a bipolar patient developing severe delirium and extrapyramidal signs shortly after initiation of a lithium-neuroleptic combination therapy. Clinical presentation, EEG changes and lithium plasma levels showed a close correlation. The delirium was reversible when all drugs were stopped; however, dyskinesia was found to be persistent after a period of 6 months. This rare syndrome is difficult to differentiate from lithium intoxication and neuroleptic malignant syndrome. Given the additional use of valproate and biperiden in this patient, valproate encephalopathy and anticholinergic delirium are further differential diagnoses. To avoid this serious pharmacodynamic drug interaction, patients should be closely monitored when lithium-neuroleptic comedication is started.
9832353	0	8	Delirium	Disease	MESH:D003693
9832353	24	34	dyskinesia	Disease	MESH:D004409
9832353	48	55	lithium	Chemical	MESH:D008094
9832353	105	112	bipolar	Disease	MESH:D001714
9832353	113	120	patient	Species	9606
9832353	139	147	delirium	Disease	MESH:D003693
9832353	152	172	extrapyramidal signs	Disease	MESH:D001480
9832353	203	210	lithium	Chemical	MESH:D008094
9832353	283	290	lithium	Chemical	MESH:D008094
9832353	337	345	delirium	Disease	MESH:D003693
9832353	399	409	dyskinesia	Disease	MESH:D004409
9832353	519	526	lithium	Chemical	MESH:D008094
9832353	544	574	neuroleptic malignant syndrome	Disease	MESH:D009459
9832353	604	613	valproate	Chemical	MESH:D014635
9832353	618	627	biperiden	Chemical	MESH:D001712
9832353	636	643	patient	Species	9606
9832353	645	654	valproate	Chemical	MESH:D014635
9832353	655	669	encephalopathy	Disease	MESH:D001927
9832353	690	698	delirium	Disease	MESH:D003693
9832353	791	799	patients	Species	9606
9832353	833	840	lithium	Chemical	MESH:D008094
9832353	Positive_Correlation	MESH:D008094	MESH:D004409
9832353	Negative_Correlation	MESH:D008094	MESH:D001714
9832353	Positive_Correlation	MESH:D001712	MESH:D001927
9832353	Cotreatment	MESH:D001712	MESH:D014635
9832353	Positive_Correlation	MESH:D008094	MESH:D001480
9832353	Positive_Correlation	MESH:D014635	MESH:D003693
9832353	Positive_Correlation	MESH:D014635	MESH:D001927
9832353	Positive_Correlation	MESH:D008094	MESH:D003693
9832353	Positive_Correlation	MESH:D008094	MESH:D001927

